ARVO to award young scientists

Article

A series of awards granted to scientists under the age of 45 has been announced by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER) and Merck & Co, Inc.

A series of awards granted to scientists under the age of 45 has been announced by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER) and Merck & Co, Inc.

The ARVO-AFER/Merck Innovative Ophthalmology Research Award (IORA) grants, totalling $70,000 per cycle, will be awarded biennially to young scientists of MD, PhD or equivalent level throughout the world who have made "innovative contributions to ophthalmology research". The awards are granted in the categories of glaucoma and back-of-eye diseases, and first and second place prizes will be awarded in each category. In addition to grant funding, award recipients will receive travel expenses and registration fees for the annual ARVO meeting.

The award, formerly run by Merck as the Chibret Award, has been granted to more than 50 scientists since its initiation in 1982. Submissions for the first ARVO-AFER/Merck IORA have now closed, and the winners will be announced at the ARVO 2009 annual meeting, to be held on May 3–7 in Fort Lauderdale, US. The application process for the 2011 award will begin in 2010.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.